Global Ophthalmic Phacoemulsification Surgery System Market Growth 2026-2032
The global Ophthalmic Phacoemulsification Surgery System market size is predicted to grow from US$ 2663 million in 2025 to US$ 3873 million in 2032; it is expected to grow at a CAGR of 5.6% from 2026 to 2032.
In 2024, the global production of ophthalmic phacoemulsification surgery systems will reach 43k sets, with an average selling price of US$60k per set. The ophthalmic phacoemulsification surgery system is a core device for modern cataract treatment. It is mainly used to emulsify the cloudy lens through ultrasonic vibration during microsurgery, then suck it out through negative pressure and implant an artificial lens to restore the patient's vision. Its operating principle is to rapidly disintegrate the lens using the high-frequency vibrations of the ultrasound probe (typically 20kHz to 60kHz). Simultaneously, an irrigation and aspiration system maintains intraocular pressure and transparency, improving surgical safety and efficiency. The system typically consists of an ultrasound unit, a handpiece probe, an irrigation and aspiration system, a control foot pedal, and an interface for monitoring surgical parameters. It features automatic adjustment of ultrasound energy, real-time intraocular pressure control, and integrated cutting and aspiration operations. Modern devices also incorporate microincision technology (MICS), intelligent energy management (to minimize thermal damage), constant intraocular pressure control, and multimodal surgical procedures to enhance surgical precision and patient comfort.
The upstream of the industry chain of ophthalmic phacoemulsification surgical systems mainly includes suppliers of core components such as ultrasonic energy generators, probe transducers (piezoelectric ceramics), optical lenses, irrigation and aspiration pumps, cutting heads, electronic control units and surgical microscopes. Representative companies include Japan's Murata (piezoelectric components), Zeiss (optical devices), Hamilton (micro pumps and consumables), etc.; the midstream is equipment manufacturers, which integrate the phacoemulsification host, handle, irrigation and aspiration system, foot control and display unit, and conduct clinical certification and registration; the downstream is aimed at hospital ophthalmology departments, ophthalmic surgery centers and chain ophthalmic institutions, and is used for cataract removal and intraocular lens implantation. It is currently the mainstream equipment for cataract surgery in the world, and demand is closely related to aging and medical accessibility.
United States market for Ophthalmic Phacoemulsification Surgery System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Ophthalmic Phacoemulsification Surgery System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Ophthalmic Phacoemulsification Surgery System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Ophthalmic Phacoemulsification Surgery System players cover Johnson & Johnson Vision, Carl Zeiss Meditec, HOYA Corporation, NIDEK Co., Ltd., Lumenis Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
This Insight Report provides a comprehensive analysis of the global Ophthalmic Phacoemulsification Surgery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ophthalmic Phacoemulsification Surgery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ophthalmic Phacoemulsification Surgery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ophthalmic Phacoemulsification Surgery System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ophthalmic Phacoemulsification Surgery System.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmic Phacoemulsification Surgery System market by product type, application, key manufacturers and key regions and countries.
In 2024, the global production of ophthalmic phacoemulsification surgery systems will reach 43k sets, with an average selling price of US$60k per set. The ophthalmic phacoemulsification surgery system is a core device for modern cataract treatment. It is mainly used to emulsify the cloudy lens through ultrasonic vibration during microsurgery, then suck it out through negative pressure and implant an artificial lens to restore the patient's vision. Its operating principle is to rapidly disintegrate the lens using the high-frequency vibrations of the ultrasound probe (typically 20kHz to 60kHz). Simultaneously, an irrigation and aspiration system maintains intraocular pressure and transparency, improving surgical safety and efficiency. The system typically consists of an ultrasound unit, a handpiece probe, an irrigation and aspiration system, a control foot pedal, and an interface for monitoring surgical parameters. It features automatic adjustment of ultrasound energy, real-time intraocular pressure control, and integrated cutting and aspiration operations. Modern devices also incorporate microincision technology (MICS), intelligent energy management (to minimize thermal damage), constant intraocular pressure control, and multimodal surgical procedures to enhance surgical precision and patient comfort.
The upstream of the industry chain of ophthalmic phacoemulsification surgical systems mainly includes suppliers of core components such as ultrasonic energy generators, probe transducers (piezoelectric ceramics), optical lenses, irrigation and aspiration pumps, cutting heads, electronic control units and surgical microscopes. Representative companies include Japan's Murata (piezoelectric components), Zeiss (optical devices), Hamilton (micro pumps and consumables), etc.; the midstream is equipment manufacturers, which integrate the phacoemulsification host, handle, irrigation and aspiration system, foot control and display unit, and conduct clinical certification and registration; the downstream is aimed at hospital ophthalmology departments, ophthalmic surgery centers and chain ophthalmic institutions, and is used for cataract removal and intraocular lens implantation. It is currently the mainstream equipment for cataract surgery in the world, and demand is closely related to aging and medical accessibility.
United States market for Ophthalmic Phacoemulsification Surgery System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Ophthalmic Phacoemulsification Surgery System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Ophthalmic Phacoemulsification Surgery System is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Ophthalmic Phacoemulsification Surgery System players cover Johnson & Johnson Vision, Carl Zeiss Meditec, HOYA Corporation, NIDEK Co., Ltd., Lumenis Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Ophthalmic Phacoemulsification Surgery System Industry Forecast” looks at past sales and reviews total world Ophthalmic Phacoemulsification Surgery System sales in 2025, providing a comprehensive analysis by region and market sector of projected Ophthalmic Phacoemulsification Surgery System sales for 2026 through 2032. With Ophthalmic Phacoemulsification Surgery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ophthalmic Phacoemulsification Surgery System industry.This Insight Report provides a comprehensive analysis of the global Ophthalmic Phacoemulsification Surgery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ophthalmic Phacoemulsification Surgery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ophthalmic Phacoemulsification Surgery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ophthalmic Phacoemulsification Surgery System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ophthalmic Phacoemulsification Surgery System.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmic Phacoemulsification Surgery System market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Long-Wave Phacoemulsification
- Short-Wave Phacoemulsification
Segmentation by Application:
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Johnson & Johnson Vision
- Carl Zeiss Meditec
- HOYA Corporation
- NIDEK Co., Ltd.
- Lumenis Ltd.
- Optikon 2000 S.p.A.
- Topcon Corporation
- Ellex Medical Lasers
- Oertli Instrumente AG
- Quantel Medical
- Sidapharm
- STAAR Surgical Company
- Alcon
- Abbott Medical
- Innolcon
- MEDA Co
- 66 Vision Tech
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Ophthalmic Phacoemulsification Surgery System market?
- What factors are driving Ophthalmic Phacoemulsification Surgery System market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Ophthalmic Phacoemulsification Surgery System market opportunities vary by end market size?
- How does Ophthalmic Phacoemulsification Surgery System break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ophthalmic Phacoemulsification Surgery System Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Ophthalmic Phacoemulsification Surgery System by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Ophthalmic Phacoemulsification Surgery System by Country/Region, 2021, 2025 & 2032
2.2 Ophthalmic Phacoemulsification Surgery System Segment by Type
2.2.1 Long-Wave Phacoemulsification
2.2.2 Short-Wave Phacoemulsification
2.2.3 Ophthalmic Phacoemulsification Surgery System Sales by Type
2.2.3.1 Global Ophthalmic Phacoemulsification Surgery System Sales Market Share by Type (2021-2026)
2.2.3.2 Global Ophthalmic Phacoemulsification Surgery System Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Ophthalmic Phacoemulsification Surgery System Sale Price by Type (2021-2026)
2.3 Ophthalmic Phacoemulsification Surgery System Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Ophthalmic Phacoemulsification Surgery System Sales by Application
2.3.4.1 Global Ophthalmic Phacoemulsification Surgery System Sale Market Share by Application (2021-2026)
2.3.4.2 Global Ophthalmic Phacoemulsification Surgery System Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Ophthalmic Phacoemulsification Surgery System Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Ophthalmic Phacoemulsification Surgery System Breakdown Data by Company
3.1.1 Global Ophthalmic Phacoemulsification Surgery System Annual Sales by Company (2021-2026)
3.1.2 Global Ophthalmic Phacoemulsification Surgery System Sales Market Share by Company (2021-2026)
3.2 Global Ophthalmic Phacoemulsification Surgery System Annual Revenue by Company (2021-2026)
3.2.1 Global Ophthalmic Phacoemulsification Surgery System Revenue by Company (2021-2026)
3.2.2 Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Company (2021-2026)
3.3 Global Ophthalmic Phacoemulsification Surgery System Sale Price by Company
3.4 Key Manufacturers Ophthalmic Phacoemulsification Surgery System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ophthalmic Phacoemulsification Surgery System Product Location Distribution
3.4.2 Players Ophthalmic Phacoemulsification Surgery System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OPHTHALMIC PHACOEMULSIFICATION SURGERY SYSTEM BY GEOGRAPHIC REGION
4.1 World Historic Ophthalmic Phacoemulsification Surgery System Market Size by Geographic Region (2021-2026)
4.1.1 Global Ophthalmic Phacoemulsification Surgery System Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Ophthalmic Phacoemulsification Surgery System Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Ophthalmic Phacoemulsification Surgery System Market Size by Country/Region (2021-2026)
4.2.1 Global Ophthalmic Phacoemulsification Surgery System Annual Sales by Country/Region (2021-2026)
4.2.2 Global Ophthalmic Phacoemulsification Surgery System Annual Revenue by Country/Region (2021-2026)
4.3 Americas Ophthalmic Phacoemulsification Surgery System Sales Growth
4.4 APAC Ophthalmic Phacoemulsification Surgery System Sales Growth
4.5 Europe Ophthalmic Phacoemulsification Surgery System Sales Growth
4.6 Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales Growth
5 AMERICAS
5.1 Americas Ophthalmic Phacoemulsification Surgery System Sales by Country
5.1.1 Americas Ophthalmic Phacoemulsification Surgery System Sales by Country (2021-2026)
5.1.2 Americas Ophthalmic Phacoemulsification Surgery System Revenue by Country (2021-2026)
5.2 Americas Ophthalmic Phacoemulsification Surgery System Sales by Type (2021-2026)
5.3 Americas Ophthalmic Phacoemulsification Surgery System Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmic Phacoemulsification Surgery System Sales by Region
6.1.1 APAC Ophthalmic Phacoemulsification Surgery System Sales by Region (2021-2026)
6.1.2 APAC Ophthalmic Phacoemulsification Surgery System Revenue by Region (2021-2026)
6.2 APAC Ophthalmic Phacoemulsification Surgery System Sales by Type (2021-2026)
6.3 APAC Ophthalmic Phacoemulsification Surgery System Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Ophthalmic Phacoemulsification Surgery System by Country
7.1.1 Europe Ophthalmic Phacoemulsification Surgery System Sales by Country (2021-2026)
7.1.2 Europe Ophthalmic Phacoemulsification Surgery System Revenue by Country (2021-2026)
7.2 Europe Ophthalmic Phacoemulsification Surgery System Sales by Type (2021-2026)
7.3 Europe Ophthalmic Phacoemulsification Surgery System Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ophthalmic Phacoemulsification Surgery System by Country
8.1.1 Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales by Country (2021-2026)
8.1.2 Middle East & Africa Ophthalmic Phacoemulsification Surgery System Revenue by Country (2021-2026)
8.2 Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales by Type (2021-2026)
8.3 Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ophthalmic Phacoemulsification Surgery System
10.3 Manufacturing Process Analysis of Ophthalmic Phacoemulsification Surgery System
10.4 Industry Chain Structure of Ophthalmic Phacoemulsification Surgery System
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ophthalmic Phacoemulsification Surgery System Distributors
11.3 Ophthalmic Phacoemulsification Surgery System Customer
12 WORLD FORECAST REVIEW FOR OPHTHALMIC PHACOEMULSIFICATION SURGERY SYSTEM BY GEOGRAPHIC REGION
12.1 Global Ophthalmic Phacoemulsification Surgery System Market Size Forecast by Region
12.1.1 Global Ophthalmic Phacoemulsification Surgery System Forecast by Region (2027-2032)
12.1.2 Global Ophthalmic Phacoemulsification Surgery System Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Ophthalmic Phacoemulsification Surgery System Forecast by Type (2027-2032)
12.7 Global Ophthalmic Phacoemulsification Surgery System Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson Vision
13.1.1 Johnson & Johnson Vision Company Information
13.1.2 Johnson & Johnson Vision Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.1.3 Johnson & Johnson Vision Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Johnson & Johnson Vision Main Business Overview
13.1.5 Johnson & Johnson Vision Latest Developments
13.2 Carl Zeiss Meditec
13.2.1 Carl Zeiss Meditec Company Information
13.2.2 Carl Zeiss Meditec Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.2.3 Carl Zeiss Meditec Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Carl Zeiss Meditec Main Business Overview
13.2.5 Carl Zeiss Meditec Latest Developments
13.3 HOYA Corporation
13.3.1 HOYA Corporation Company Information
13.3.2 HOYA Corporation Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.3.3 HOYA Corporation Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 HOYA Corporation Main Business Overview
13.3.5 HOYA Corporation Latest Developments
13.4 NIDEK Co., Ltd.
13.4.1 NIDEK Co., Ltd. Company Information
13.4.2 NIDEK Co., Ltd. Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.4.3 NIDEK Co., Ltd. Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 NIDEK Co., Ltd. Main Business Overview
13.4.5 NIDEK Co., Ltd. Latest Developments
13.5 Lumenis Ltd.
13.5.1 Lumenis Ltd. Company Information
13.5.2 Lumenis Ltd. Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.5.3 Lumenis Ltd. Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Lumenis Ltd. Main Business Overview
13.5.5 Lumenis Ltd. Latest Developments
13.6 Optikon 2000 S.p.A.
13.6.1 Optikon 2000 S.p.A. Company Information
13.6.2 Optikon 2000 S.p.A. Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.6.3 Optikon 2000 S.p.A. Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Optikon 2000 S.p.A. Main Business Overview
13.6.5 Optikon 2000 S.p.A. Latest Developments
13.7 Topcon Corporation
13.7.1 Topcon Corporation Company Information
13.7.2 Topcon Corporation Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.7.3 Topcon Corporation Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Topcon Corporation Main Business Overview
13.7.5 Topcon Corporation Latest Developments
13.8 Ellex Medical Lasers
13.8.1 Ellex Medical Lasers Company Information
13.8.2 Ellex Medical Lasers Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.8.3 Ellex Medical Lasers Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Ellex Medical Lasers Main Business Overview
13.8.5 Ellex Medical Lasers Latest Developments
13.9 Oertli Instrumente AG
13.9.1 Oertli Instrumente AG Company Information
13.9.2 Oertli Instrumente AG Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.9.3 Oertli Instrumente AG Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Oertli Instrumente AG Main Business Overview
13.9.5 Oertli Instrumente AG Latest Developments
13.10 Quantel Medical
13.10.1 Quantel Medical Company Information
13.10.2 Quantel Medical Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.10.3 Quantel Medical Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Quantel Medical Main Business Overview
13.10.5 Quantel Medical Latest Developments
13.11 Sidapharm
13.11.1 Sidapharm Company Information
13.11.2 Sidapharm Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.11.3 Sidapharm Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Sidapharm Main Business Overview
13.11.5 Sidapharm Latest Developments
13.12 STAAR Surgical Company
13.12.1 STAAR Surgical Company Company Information
13.12.2 STAAR Surgical Company Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.12.3 STAAR Surgical Company Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 STAAR Surgical Company Main Business Overview
13.12.5 STAAR Surgical Company Latest Developments
13.13 Alcon
13.13.1 Alcon Company Information
13.13.2 Alcon Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.13.3 Alcon Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Alcon Main Business Overview
13.13.5 Alcon Latest Developments
13.14 Abbott Medical
13.14.1 Abbott Medical Company Information
13.14.2 Abbott Medical Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.14.3 Abbott Medical Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Abbott Medical Main Business Overview
13.14.5 Abbott Medical Latest Developments
13.15 Innolcon
13.15.1 Innolcon Company Information
13.15.2 Innolcon Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.15.3 Innolcon Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Innolcon Main Business Overview
13.15.5 Innolcon Latest Developments
13.16 MEDA Co
13.16.1 MEDA Co Company Information
13.16.2 MEDA Co Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.16.3 MEDA Co Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 MEDA Co Main Business Overview
13.16.5 MEDA Co Latest Developments
13.17 66 Vision Tech
13.17.1 66 Vision Tech Company Information
13.17.2 66 Vision Tech Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.17.3 66 Vision Tech Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 66 Vision Tech Main Business Overview
13.17.5 66 Vision Tech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ophthalmic Phacoemulsification Surgery System Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Ophthalmic Phacoemulsification Surgery System by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Ophthalmic Phacoemulsification Surgery System by Country/Region, 2021, 2025 & 2032
2.2 Ophthalmic Phacoemulsification Surgery System Segment by Type
2.2.1 Long-Wave Phacoemulsification
2.2.2 Short-Wave Phacoemulsification
2.2.3 Ophthalmic Phacoemulsification Surgery System Sales by Type
2.2.3.1 Global Ophthalmic Phacoemulsification Surgery System Sales Market Share by Type (2021-2026)
2.2.3.2 Global Ophthalmic Phacoemulsification Surgery System Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Ophthalmic Phacoemulsification Surgery System Sale Price by Type (2021-2026)
2.3 Ophthalmic Phacoemulsification Surgery System Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Ophthalmic Phacoemulsification Surgery System Sales by Application
2.3.4.1 Global Ophthalmic Phacoemulsification Surgery System Sale Market Share by Application (2021-2026)
2.3.4.2 Global Ophthalmic Phacoemulsification Surgery System Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Ophthalmic Phacoemulsification Surgery System Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Ophthalmic Phacoemulsification Surgery System Breakdown Data by Company
3.1.1 Global Ophthalmic Phacoemulsification Surgery System Annual Sales by Company (2021-2026)
3.1.2 Global Ophthalmic Phacoemulsification Surgery System Sales Market Share by Company (2021-2026)
3.2 Global Ophthalmic Phacoemulsification Surgery System Annual Revenue by Company (2021-2026)
3.2.1 Global Ophthalmic Phacoemulsification Surgery System Revenue by Company (2021-2026)
3.2.2 Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Company (2021-2026)
3.3 Global Ophthalmic Phacoemulsification Surgery System Sale Price by Company
3.4 Key Manufacturers Ophthalmic Phacoemulsification Surgery System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ophthalmic Phacoemulsification Surgery System Product Location Distribution
3.4.2 Players Ophthalmic Phacoemulsification Surgery System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OPHTHALMIC PHACOEMULSIFICATION SURGERY SYSTEM BY GEOGRAPHIC REGION
4.1 World Historic Ophthalmic Phacoemulsification Surgery System Market Size by Geographic Region (2021-2026)
4.1.1 Global Ophthalmic Phacoemulsification Surgery System Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Ophthalmic Phacoemulsification Surgery System Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Ophthalmic Phacoemulsification Surgery System Market Size by Country/Region (2021-2026)
4.2.1 Global Ophthalmic Phacoemulsification Surgery System Annual Sales by Country/Region (2021-2026)
4.2.2 Global Ophthalmic Phacoemulsification Surgery System Annual Revenue by Country/Region (2021-2026)
4.3 Americas Ophthalmic Phacoemulsification Surgery System Sales Growth
4.4 APAC Ophthalmic Phacoemulsification Surgery System Sales Growth
4.5 Europe Ophthalmic Phacoemulsification Surgery System Sales Growth
4.6 Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales Growth
5 AMERICAS
5.1 Americas Ophthalmic Phacoemulsification Surgery System Sales by Country
5.1.1 Americas Ophthalmic Phacoemulsification Surgery System Sales by Country (2021-2026)
5.1.2 Americas Ophthalmic Phacoemulsification Surgery System Revenue by Country (2021-2026)
5.2 Americas Ophthalmic Phacoemulsification Surgery System Sales by Type (2021-2026)
5.3 Americas Ophthalmic Phacoemulsification Surgery System Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmic Phacoemulsification Surgery System Sales by Region
6.1.1 APAC Ophthalmic Phacoemulsification Surgery System Sales by Region (2021-2026)
6.1.2 APAC Ophthalmic Phacoemulsification Surgery System Revenue by Region (2021-2026)
6.2 APAC Ophthalmic Phacoemulsification Surgery System Sales by Type (2021-2026)
6.3 APAC Ophthalmic Phacoemulsification Surgery System Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Ophthalmic Phacoemulsification Surgery System by Country
7.1.1 Europe Ophthalmic Phacoemulsification Surgery System Sales by Country (2021-2026)
7.1.2 Europe Ophthalmic Phacoemulsification Surgery System Revenue by Country (2021-2026)
7.2 Europe Ophthalmic Phacoemulsification Surgery System Sales by Type (2021-2026)
7.3 Europe Ophthalmic Phacoemulsification Surgery System Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ophthalmic Phacoemulsification Surgery System by Country
8.1.1 Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales by Country (2021-2026)
8.1.2 Middle East & Africa Ophthalmic Phacoemulsification Surgery System Revenue by Country (2021-2026)
8.2 Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales by Type (2021-2026)
8.3 Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ophthalmic Phacoemulsification Surgery System
10.3 Manufacturing Process Analysis of Ophthalmic Phacoemulsification Surgery System
10.4 Industry Chain Structure of Ophthalmic Phacoemulsification Surgery System
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ophthalmic Phacoemulsification Surgery System Distributors
11.3 Ophthalmic Phacoemulsification Surgery System Customer
12 WORLD FORECAST REVIEW FOR OPHTHALMIC PHACOEMULSIFICATION SURGERY SYSTEM BY GEOGRAPHIC REGION
12.1 Global Ophthalmic Phacoemulsification Surgery System Market Size Forecast by Region
12.1.1 Global Ophthalmic Phacoemulsification Surgery System Forecast by Region (2027-2032)
12.1.2 Global Ophthalmic Phacoemulsification Surgery System Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Ophthalmic Phacoemulsification Surgery System Forecast by Type (2027-2032)
12.7 Global Ophthalmic Phacoemulsification Surgery System Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Johnson & Johnson Vision
13.1.1 Johnson & Johnson Vision Company Information
13.1.2 Johnson & Johnson Vision Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.1.3 Johnson & Johnson Vision Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Johnson & Johnson Vision Main Business Overview
13.1.5 Johnson & Johnson Vision Latest Developments
13.2 Carl Zeiss Meditec
13.2.1 Carl Zeiss Meditec Company Information
13.2.2 Carl Zeiss Meditec Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.2.3 Carl Zeiss Meditec Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Carl Zeiss Meditec Main Business Overview
13.2.5 Carl Zeiss Meditec Latest Developments
13.3 HOYA Corporation
13.3.1 HOYA Corporation Company Information
13.3.2 HOYA Corporation Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.3.3 HOYA Corporation Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 HOYA Corporation Main Business Overview
13.3.5 HOYA Corporation Latest Developments
13.4 NIDEK Co., Ltd.
13.4.1 NIDEK Co., Ltd. Company Information
13.4.2 NIDEK Co., Ltd. Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.4.3 NIDEK Co., Ltd. Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 NIDEK Co., Ltd. Main Business Overview
13.4.5 NIDEK Co., Ltd. Latest Developments
13.5 Lumenis Ltd.
13.5.1 Lumenis Ltd. Company Information
13.5.2 Lumenis Ltd. Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.5.3 Lumenis Ltd. Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Lumenis Ltd. Main Business Overview
13.5.5 Lumenis Ltd. Latest Developments
13.6 Optikon 2000 S.p.A.
13.6.1 Optikon 2000 S.p.A. Company Information
13.6.2 Optikon 2000 S.p.A. Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.6.3 Optikon 2000 S.p.A. Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Optikon 2000 S.p.A. Main Business Overview
13.6.5 Optikon 2000 S.p.A. Latest Developments
13.7 Topcon Corporation
13.7.1 Topcon Corporation Company Information
13.7.2 Topcon Corporation Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.7.3 Topcon Corporation Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Topcon Corporation Main Business Overview
13.7.5 Topcon Corporation Latest Developments
13.8 Ellex Medical Lasers
13.8.1 Ellex Medical Lasers Company Information
13.8.2 Ellex Medical Lasers Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.8.3 Ellex Medical Lasers Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Ellex Medical Lasers Main Business Overview
13.8.5 Ellex Medical Lasers Latest Developments
13.9 Oertli Instrumente AG
13.9.1 Oertli Instrumente AG Company Information
13.9.2 Oertli Instrumente AG Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.9.3 Oertli Instrumente AG Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Oertli Instrumente AG Main Business Overview
13.9.5 Oertli Instrumente AG Latest Developments
13.10 Quantel Medical
13.10.1 Quantel Medical Company Information
13.10.2 Quantel Medical Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.10.3 Quantel Medical Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Quantel Medical Main Business Overview
13.10.5 Quantel Medical Latest Developments
13.11 Sidapharm
13.11.1 Sidapharm Company Information
13.11.2 Sidapharm Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.11.3 Sidapharm Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Sidapharm Main Business Overview
13.11.5 Sidapharm Latest Developments
13.12 STAAR Surgical Company
13.12.1 STAAR Surgical Company Company Information
13.12.2 STAAR Surgical Company Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.12.3 STAAR Surgical Company Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 STAAR Surgical Company Main Business Overview
13.12.5 STAAR Surgical Company Latest Developments
13.13 Alcon
13.13.1 Alcon Company Information
13.13.2 Alcon Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.13.3 Alcon Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Alcon Main Business Overview
13.13.5 Alcon Latest Developments
13.14 Abbott Medical
13.14.1 Abbott Medical Company Information
13.14.2 Abbott Medical Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.14.3 Abbott Medical Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Abbott Medical Main Business Overview
13.14.5 Abbott Medical Latest Developments
13.15 Innolcon
13.15.1 Innolcon Company Information
13.15.2 Innolcon Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.15.3 Innolcon Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Innolcon Main Business Overview
13.15.5 Innolcon Latest Developments
13.16 MEDA Co
13.16.1 MEDA Co Company Information
13.16.2 MEDA Co Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.16.3 MEDA Co Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 MEDA Co Main Business Overview
13.16.5 MEDA Co Latest Developments
13.17 66 Vision Tech
13.17.1 66 Vision Tech Company Information
13.17.2 66 Vision Tech Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
13.17.3 66 Vision Tech Ophthalmic Phacoemulsification Surgery System Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 66 Vision Tech Main Business Overview
13.17.5 66 Vision Tech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Ophthalmic Phacoemulsification Surgery System Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Ophthalmic Phacoemulsification Surgery System Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Long-Wave Phacoemulsification
Table 4. Major Players of Short-Wave Phacoemulsification
Table 5. Global Ophthalmic Phacoemulsification Surgery System Sales by Type (2021-2026) & (K Units)
Table 6. Global Ophthalmic Phacoemulsification Surgery System Sales Market Share by Type (2021-2026)
Table 7. Global Ophthalmic Phacoemulsification Surgery System Revenue by Type (2021-2026) & ($ million)
Table 8. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Type (2021-2026)
Table 9. Global Ophthalmic Phacoemulsification Surgery System Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Ophthalmic Phacoemulsification Surgery System Sale by Application (2021-2026) & (K Units)
Table 11. Global Ophthalmic Phacoemulsification Surgery System Sale Market Share by Application (2021-2026)
Table 12. Global Ophthalmic Phacoemulsification Surgery System Revenue by Application (2021-2026) & ($ million)
Table 13. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Application (2021-2026)
Table 14. Global Ophthalmic Phacoemulsification Surgery System Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Ophthalmic Phacoemulsification Surgery System Sales by Company (2021-2026) & (K Units)
Table 16. Global Ophthalmic Phacoemulsification Surgery System Sales Market Share by Company (2021-2026)
Table 17. Global Ophthalmic Phacoemulsification Surgery System Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Company (2021-2026)
Table 19. Global Ophthalmic Phacoemulsification Surgery System Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Ophthalmic Phacoemulsification Surgery System Producing Area Distribution and Sales Area
Table 21. Players Ophthalmic Phacoemulsification Surgery System Products Offered
Table 22. Ophthalmic Phacoemulsification Surgery System Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Ophthalmic Phacoemulsification Surgery System Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Ophthalmic Phacoemulsification Surgery System Sales Market Share Geographic Region (2021-2026)
Table 27. Global Ophthalmic Phacoemulsification Surgery System Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Ophthalmic Phacoemulsification Surgery System Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Ophthalmic Phacoemulsification Surgery System Sales Market Share by Country/Region (2021-2026)
Table 31. Global Ophthalmic Phacoemulsification Surgery System Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Ophthalmic Phacoemulsification Surgery System Sales by Country (2021-2026) & (K Units)
Table 34. Americas Ophthalmic Phacoemulsification Surgery System Sales Market Share by Country (2021-2026)
Table 35. Americas Ophthalmic Phacoemulsification Surgery System Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Ophthalmic Phacoemulsification Surgery System Sales by Type (2021-2026) & (K Units)
Table 37. Americas Ophthalmic Phacoemulsification Surgery System Sales by Application (2021-2026) & (K Units)
Table 38. APAC Ophthalmic Phacoemulsification Surgery System Sales by Region (2021-2026) & (K Units)
Table 39. APAC Ophthalmic Phacoemulsification Surgery System Sales Market Share by Region (2021-2026)
Table 40. APAC Ophthalmic Phacoemulsification Surgery System Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Ophthalmic Phacoemulsification Surgery System Sales by Type (2021-2026) & (K Units)
Table 42. APAC Ophthalmic Phacoemulsification Surgery System Sales by Application (2021-2026) & (K Units)
Table 43. Europe Ophthalmic Phacoemulsification Surgery System Sales by Country (2021-2026) & (K Units)
Table 44. Europe Ophthalmic Phacoemulsification Surgery System Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Ophthalmic Phacoemulsification Surgery System Sales by Type (2021-2026) & (K Units)
Table 46. Europe Ophthalmic Phacoemulsification Surgery System Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Ophthalmic Phacoemulsification Surgery System
Table 52. Key Market Challenges & Risks of Ophthalmic Phacoemulsification Surgery System
Table 53. Key Industry Trends of Ophthalmic Phacoemulsification Surgery System
Table 54. Ophthalmic Phacoemulsification Surgery System Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Ophthalmic Phacoemulsification Surgery System Distributors List
Table 57. Ophthalmic Phacoemulsification Surgery System Customer List
Table 58. Global Ophthalmic Phacoemulsification Surgery System Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Ophthalmic Phacoemulsification Surgery System Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Ophthalmic Phacoemulsification Surgery System Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Ophthalmic Phacoemulsification Surgery System Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Ophthalmic Phacoemulsification Surgery System Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Ophthalmic Phacoemulsification Surgery System Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Ophthalmic Phacoemulsification Surgery System Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Ophthalmic Phacoemulsification Surgery System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Ophthalmic Phacoemulsification Surgery System Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Ophthalmic Phacoemulsification Surgery System Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Ophthalmic Phacoemulsification Surgery System Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Ophthalmic Phacoemulsification Surgery System Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Johnson & Johnson Vision Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 73. Johnson & Johnson Vision Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 74. Johnson & Johnson Vision Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Johnson & Johnson Vision Main Business
Table 76. Johnson & Johnson Vision Latest Developments
Table 77. Carl Zeiss Meditec Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 78. Carl Zeiss Meditec Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 79. Carl Zeiss Meditec Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Carl Zeiss Meditec Main Business
Table 81. Carl Zeiss Meditec Latest Developments
Table 82. HOYA Corporation Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 83. HOYA Corporation Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 84. HOYA Corporation Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. HOYA Corporation Main Business
Table 86. HOYA Corporation Latest Developments
Table 87. NIDEK Co., Ltd. Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 88. NIDEK Co., Ltd. Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 89. NIDEK Co., Ltd. Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. NIDEK Co., Ltd. Main Business
Table 91. NIDEK Co., Ltd. Latest Developments
Table 92. Lumenis Ltd. Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 93. Lumenis Ltd. Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 94. Lumenis Ltd. Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Lumenis Ltd. Main Business
Table 96. Lumenis Ltd. Latest Developments
Table 97. Optikon 2000 S.p.A. Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 98. Optikon 2000 S.p.A. Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 99. Optikon 2000 S.p.A. Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Optikon 2000 S.p.A. Main Business
Table 101. Optikon 2000 S.p.A. Latest Developments
Table 102. Topcon Corporation Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 103. Topcon Corporation Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 104. Topcon Corporation Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Topcon Corporation Main Business
Table 106. Topcon Corporation Latest Developments
Table 107. Ellex Medical Lasers Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 108. Ellex Medical Lasers Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 109. Ellex Medical Lasers Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Ellex Medical Lasers Main Business
Table 111. Ellex Medical Lasers Latest Developments
Table 112. Oertli Instrumente AG Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 113. Oertli Instrumente AG Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 114. Oertli Instrumente AG Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Oertli Instrumente AG Main Business
Table 116. Oertli Instrumente AG Latest Developments
Table 117. Quantel Medical Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 118. Quantel Medical Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 119. Quantel Medical Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Quantel Medical Main Business
Table 121. Quantel Medical Latest Developments
Table 122. Sidapharm Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 123. Sidapharm Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 124. Sidapharm Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Sidapharm Main Business
Table 126. Sidapharm Latest Developments
Table 127. STAAR Surgical Company Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 128. STAAR Surgical Company Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 129. STAAR Surgical Company Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. STAAR Surgical Company Main Business
Table 131. STAAR Surgical Company Latest Developments
Table 132. Alcon Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 133. Alcon Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 134. Alcon Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Alcon Main Business
Table 136. Alcon Latest Developments
Table 137. Abbott Medical Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 138. Abbott Medical Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 139. Abbott Medical Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Abbott Medical Main Business
Table 141. Abbott Medical Latest Developments
Table 142. Innolcon Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 143. Innolcon Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 144. Innolcon Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Innolcon Main Business
Table 146. Innolcon Latest Developments
Table 147. MEDA Co Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 148. MEDA Co Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 149. MEDA Co Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. MEDA Co Main Business
Table 151. MEDA Co Latest Developments
Table 152. 66 Vision Tech Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 153. 66 Vision Tech Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 154. 66 Vision Tech Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. 66 Vision Tech Main Business
Table 156. 66 Vision Tech Latest Developments
Table 1. Ophthalmic Phacoemulsification Surgery System Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Ophthalmic Phacoemulsification Surgery System Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Long-Wave Phacoemulsification
Table 4. Major Players of Short-Wave Phacoemulsification
Table 5. Global Ophthalmic Phacoemulsification Surgery System Sales by Type (2021-2026) & (K Units)
Table 6. Global Ophthalmic Phacoemulsification Surgery System Sales Market Share by Type (2021-2026)
Table 7. Global Ophthalmic Phacoemulsification Surgery System Revenue by Type (2021-2026) & ($ million)
Table 8. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Type (2021-2026)
Table 9. Global Ophthalmic Phacoemulsification Surgery System Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Ophthalmic Phacoemulsification Surgery System Sale by Application (2021-2026) & (K Units)
Table 11. Global Ophthalmic Phacoemulsification Surgery System Sale Market Share by Application (2021-2026)
Table 12. Global Ophthalmic Phacoemulsification Surgery System Revenue by Application (2021-2026) & ($ million)
Table 13. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Application (2021-2026)
Table 14. Global Ophthalmic Phacoemulsification Surgery System Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Ophthalmic Phacoemulsification Surgery System Sales by Company (2021-2026) & (K Units)
Table 16. Global Ophthalmic Phacoemulsification Surgery System Sales Market Share by Company (2021-2026)
Table 17. Global Ophthalmic Phacoemulsification Surgery System Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Company (2021-2026)
Table 19. Global Ophthalmic Phacoemulsification Surgery System Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Ophthalmic Phacoemulsification Surgery System Producing Area Distribution and Sales Area
Table 21. Players Ophthalmic Phacoemulsification Surgery System Products Offered
Table 22. Ophthalmic Phacoemulsification Surgery System Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Ophthalmic Phacoemulsification Surgery System Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Ophthalmic Phacoemulsification Surgery System Sales Market Share Geographic Region (2021-2026)
Table 27. Global Ophthalmic Phacoemulsification Surgery System Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Ophthalmic Phacoemulsification Surgery System Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Ophthalmic Phacoemulsification Surgery System Sales Market Share by Country/Region (2021-2026)
Table 31. Global Ophthalmic Phacoemulsification Surgery System Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Ophthalmic Phacoemulsification Surgery System Sales by Country (2021-2026) & (K Units)
Table 34. Americas Ophthalmic Phacoemulsification Surgery System Sales Market Share by Country (2021-2026)
Table 35. Americas Ophthalmic Phacoemulsification Surgery System Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Ophthalmic Phacoemulsification Surgery System Sales by Type (2021-2026) & (K Units)
Table 37. Americas Ophthalmic Phacoemulsification Surgery System Sales by Application (2021-2026) & (K Units)
Table 38. APAC Ophthalmic Phacoemulsification Surgery System Sales by Region (2021-2026) & (K Units)
Table 39. APAC Ophthalmic Phacoemulsification Surgery System Sales Market Share by Region (2021-2026)
Table 40. APAC Ophthalmic Phacoemulsification Surgery System Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Ophthalmic Phacoemulsification Surgery System Sales by Type (2021-2026) & (K Units)
Table 42. APAC Ophthalmic Phacoemulsification Surgery System Sales by Application (2021-2026) & (K Units)
Table 43. Europe Ophthalmic Phacoemulsification Surgery System Sales by Country (2021-2026) & (K Units)
Table 44. Europe Ophthalmic Phacoemulsification Surgery System Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Ophthalmic Phacoemulsification Surgery System Sales by Type (2021-2026) & (K Units)
Table 46. Europe Ophthalmic Phacoemulsification Surgery System Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Ophthalmic Phacoemulsification Surgery System
Table 52. Key Market Challenges & Risks of Ophthalmic Phacoemulsification Surgery System
Table 53. Key Industry Trends of Ophthalmic Phacoemulsification Surgery System
Table 54. Ophthalmic Phacoemulsification Surgery System Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Ophthalmic Phacoemulsification Surgery System Distributors List
Table 57. Ophthalmic Phacoemulsification Surgery System Customer List
Table 58. Global Ophthalmic Phacoemulsification Surgery System Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Ophthalmic Phacoemulsification Surgery System Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Ophthalmic Phacoemulsification Surgery System Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Ophthalmic Phacoemulsification Surgery System Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Ophthalmic Phacoemulsification Surgery System Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Ophthalmic Phacoemulsification Surgery System Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Ophthalmic Phacoemulsification Surgery System Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Ophthalmic Phacoemulsification Surgery System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Ophthalmic Phacoemulsification Surgery System Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Ophthalmic Phacoemulsification Surgery System Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Ophthalmic Phacoemulsification Surgery System Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Ophthalmic Phacoemulsification Surgery System Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Johnson & Johnson Vision Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 73. Johnson & Johnson Vision Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 74. Johnson & Johnson Vision Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Johnson & Johnson Vision Main Business
Table 76. Johnson & Johnson Vision Latest Developments
Table 77. Carl Zeiss Meditec Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 78. Carl Zeiss Meditec Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 79. Carl Zeiss Meditec Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Carl Zeiss Meditec Main Business
Table 81. Carl Zeiss Meditec Latest Developments
Table 82. HOYA Corporation Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 83. HOYA Corporation Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 84. HOYA Corporation Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. HOYA Corporation Main Business
Table 86. HOYA Corporation Latest Developments
Table 87. NIDEK Co., Ltd. Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 88. NIDEK Co., Ltd. Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 89. NIDEK Co., Ltd. Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. NIDEK Co., Ltd. Main Business
Table 91. NIDEK Co., Ltd. Latest Developments
Table 92. Lumenis Ltd. Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 93. Lumenis Ltd. Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 94. Lumenis Ltd. Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Lumenis Ltd. Main Business
Table 96. Lumenis Ltd. Latest Developments
Table 97. Optikon 2000 S.p.A. Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 98. Optikon 2000 S.p.A. Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 99. Optikon 2000 S.p.A. Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Optikon 2000 S.p.A. Main Business
Table 101. Optikon 2000 S.p.A. Latest Developments
Table 102. Topcon Corporation Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 103. Topcon Corporation Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 104. Topcon Corporation Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Topcon Corporation Main Business
Table 106. Topcon Corporation Latest Developments
Table 107. Ellex Medical Lasers Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 108. Ellex Medical Lasers Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 109. Ellex Medical Lasers Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Ellex Medical Lasers Main Business
Table 111. Ellex Medical Lasers Latest Developments
Table 112. Oertli Instrumente AG Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 113. Oertli Instrumente AG Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 114. Oertli Instrumente AG Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Oertli Instrumente AG Main Business
Table 116. Oertli Instrumente AG Latest Developments
Table 117. Quantel Medical Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 118. Quantel Medical Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 119. Quantel Medical Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Quantel Medical Main Business
Table 121. Quantel Medical Latest Developments
Table 122. Sidapharm Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 123. Sidapharm Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 124. Sidapharm Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Sidapharm Main Business
Table 126. Sidapharm Latest Developments
Table 127. STAAR Surgical Company Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 128. STAAR Surgical Company Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 129. STAAR Surgical Company Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. STAAR Surgical Company Main Business
Table 131. STAAR Surgical Company Latest Developments
Table 132. Alcon Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 133. Alcon Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 134. Alcon Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Alcon Main Business
Table 136. Alcon Latest Developments
Table 137. Abbott Medical Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 138. Abbott Medical Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 139. Abbott Medical Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Abbott Medical Main Business
Table 141. Abbott Medical Latest Developments
Table 142. Innolcon Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 143. Innolcon Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 144. Innolcon Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Innolcon Main Business
Table 146. Innolcon Latest Developments
Table 147. MEDA Co Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 148. MEDA Co Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 149. MEDA Co Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. MEDA Co Main Business
Table 151. MEDA Co Latest Developments
Table 152. 66 Vision Tech Basic Information, Ophthalmic Phacoemulsification Surgery System Manufacturing Base, Sales Area and Its Competitors
Table 153. 66 Vision Tech Ophthalmic Phacoemulsification Surgery System Product Portfolios and Specifications
Table 154. 66 Vision Tech Ophthalmic Phacoemulsification Surgery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. 66 Vision Tech Main Business
Table 156. 66 Vision Tech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Ophthalmic Phacoemulsification Surgery System
Figure 2. Ophthalmic Phacoemulsification Surgery System Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ophthalmic Phacoemulsification Surgery System Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Ophthalmic Phacoemulsification Surgery System Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Ophthalmic Phacoemulsification Surgery System Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Ophthalmic Phacoemulsification Surgery System Sales Market Share by Country/Region (2025)
Figure 10. Ophthalmic Phacoemulsification Surgery System Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Long-Wave Phacoemulsification
Figure 12. Product Picture of Short-Wave Phacoemulsification
Figure 13. Global Ophthalmic Phacoemulsification Surgery System Sales Market Share by Type in 2026
Figure 14. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Type (2021-2026)
Figure 15. Ophthalmic Phacoemulsification Surgery System Consumed in Hospital
Figure 16. Global Ophthalmic Phacoemulsification Surgery System Market: Hospital (2021-2026) & (K Units)
Figure 17. Ophthalmic Phacoemulsification Surgery System Consumed in Clinic
Figure 18. Global Ophthalmic Phacoemulsification Surgery System Market: Clinic (2021-2026) & (K Units)
Figure 19. Ophthalmic Phacoemulsification Surgery System Consumed in Others
Figure 20. Global Ophthalmic Phacoemulsification Surgery System Market: Others (2021-2026) & (K Units)
Figure 21. Global Ophthalmic Phacoemulsification Surgery System Sale Market Share by Application (2025)
Figure 22. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Application in 2026
Figure 23. Ophthalmic Phacoemulsification Surgery System Sales by Company in 2026 (K Units)
Figure 24. Global Ophthalmic Phacoemulsification Surgery System Sales Market Share by Company in 2026
Figure 25. Ophthalmic Phacoemulsification Surgery System Revenue by Company in 2026 ($ millions)
Figure 26. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Company in 2026
Figure 27. Global Ophthalmic Phacoemulsification Surgery System Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Ophthalmic Phacoemulsification Surgery System Sales 2021-2026 (K Units)
Figure 30. Americas Ophthalmic Phacoemulsification Surgery System Revenue 2021-2026 ($ millions)
Figure 31. APAC Ophthalmic Phacoemulsification Surgery System Sales 2021-2026 (K Units)
Figure 32. APAC Ophthalmic Phacoemulsification Surgery System Revenue 2021-2026 ($ millions)
Figure 33. Europe Ophthalmic Phacoemulsification Surgery System Sales 2021-2026 (K Units)
Figure 34. Europe Ophthalmic Phacoemulsification Surgery System Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Revenue 2021-2026 ($ millions)
Figure 37. Americas Ophthalmic Phacoemulsification Surgery System Sales Market Share by Country in 2026
Figure 38. Americas Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Country (2021-2026)
Figure 39. Americas Ophthalmic Phacoemulsification Surgery System Sales Market Share by Type (2021-2026)
Figure 40. Americas Ophthalmic Phacoemulsification Surgery System Sales Market Share by Application (2021-2026)
Figure 41. United States Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Ophthalmic Phacoemulsification Surgery System Sales Market Share by Region in 2026
Figure 46. APAC Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Region (2021-2026)
Figure 47. APAC Ophthalmic Phacoemulsification Surgery System Sales Market Share by Type (2021-2026)
Figure 48. APAC Ophthalmic Phacoemulsification Surgery System Sales Market Share by Application (2021-2026)
Figure 49. China Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 53. India Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Ophthalmic Phacoemulsification Surgery System Sales Market Share by Country in 2026
Figure 57. Europe Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Country (2021-2026)
Figure 58. Europe Ophthalmic Phacoemulsification Surgery System Sales Market Share by Type (2021-2026)
Figure 59. Europe Ophthalmic Phacoemulsification Surgery System Sales Market Share by Application (2021-2026)
Figure 60. Germany Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 61. France Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales Market Share by Application (2021-2026)
Figure 68. Egypt Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Ophthalmic Phacoemulsification Surgery System in 2026
Figure 74. Manufacturing Process Analysis of Ophthalmic Phacoemulsification Surgery System
Figure 75. Industry Chain Structure of Ophthalmic Phacoemulsification Surgery System
Figure 76. Channels of Distribution
Figure 77. Global Ophthalmic Phacoemulsification Surgery System Sales Market Forecast by Region (2027-2032)
Figure 78. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Ophthalmic Phacoemulsification Surgery System Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Ophthalmic Phacoemulsification Surgery System Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Ophthalmic Phacoemulsification Surgery System
Figure 2. Ophthalmic Phacoemulsification Surgery System Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ophthalmic Phacoemulsification Surgery System Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Ophthalmic Phacoemulsification Surgery System Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Ophthalmic Phacoemulsification Surgery System Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Ophthalmic Phacoemulsification Surgery System Sales Market Share by Country/Region (2025)
Figure 10. Ophthalmic Phacoemulsification Surgery System Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Long-Wave Phacoemulsification
Figure 12. Product Picture of Short-Wave Phacoemulsification
Figure 13. Global Ophthalmic Phacoemulsification Surgery System Sales Market Share by Type in 2026
Figure 14. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Type (2021-2026)
Figure 15. Ophthalmic Phacoemulsification Surgery System Consumed in Hospital
Figure 16. Global Ophthalmic Phacoemulsification Surgery System Market: Hospital (2021-2026) & (K Units)
Figure 17. Ophthalmic Phacoemulsification Surgery System Consumed in Clinic
Figure 18. Global Ophthalmic Phacoemulsification Surgery System Market: Clinic (2021-2026) & (K Units)
Figure 19. Ophthalmic Phacoemulsification Surgery System Consumed in Others
Figure 20. Global Ophthalmic Phacoemulsification Surgery System Market: Others (2021-2026) & (K Units)
Figure 21. Global Ophthalmic Phacoemulsification Surgery System Sale Market Share by Application (2025)
Figure 22. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Application in 2026
Figure 23. Ophthalmic Phacoemulsification Surgery System Sales by Company in 2026 (K Units)
Figure 24. Global Ophthalmic Phacoemulsification Surgery System Sales Market Share by Company in 2026
Figure 25. Ophthalmic Phacoemulsification Surgery System Revenue by Company in 2026 ($ millions)
Figure 26. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Company in 2026
Figure 27. Global Ophthalmic Phacoemulsification Surgery System Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Ophthalmic Phacoemulsification Surgery System Sales 2021-2026 (K Units)
Figure 30. Americas Ophthalmic Phacoemulsification Surgery System Revenue 2021-2026 ($ millions)
Figure 31. APAC Ophthalmic Phacoemulsification Surgery System Sales 2021-2026 (K Units)
Figure 32. APAC Ophthalmic Phacoemulsification Surgery System Revenue 2021-2026 ($ millions)
Figure 33. Europe Ophthalmic Phacoemulsification Surgery System Sales 2021-2026 (K Units)
Figure 34. Europe Ophthalmic Phacoemulsification Surgery System Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Revenue 2021-2026 ($ millions)
Figure 37. Americas Ophthalmic Phacoemulsification Surgery System Sales Market Share by Country in 2026
Figure 38. Americas Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Country (2021-2026)
Figure 39. Americas Ophthalmic Phacoemulsification Surgery System Sales Market Share by Type (2021-2026)
Figure 40. Americas Ophthalmic Phacoemulsification Surgery System Sales Market Share by Application (2021-2026)
Figure 41. United States Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Ophthalmic Phacoemulsification Surgery System Sales Market Share by Region in 2026
Figure 46. APAC Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Region (2021-2026)
Figure 47. APAC Ophthalmic Phacoemulsification Surgery System Sales Market Share by Type (2021-2026)
Figure 48. APAC Ophthalmic Phacoemulsification Surgery System Sales Market Share by Application (2021-2026)
Figure 49. China Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 53. India Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Ophthalmic Phacoemulsification Surgery System Sales Market Share by Country in 2026
Figure 57. Europe Ophthalmic Phacoemulsification Surgery System Revenue Market Share by Country (2021-2026)
Figure 58. Europe Ophthalmic Phacoemulsification Surgery System Sales Market Share by Type (2021-2026)
Figure 59. Europe Ophthalmic Phacoemulsification Surgery System Sales Market Share by Application (2021-2026)
Figure 60. Germany Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 61. France Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Ophthalmic Phacoemulsification Surgery System Sales Market Share by Application (2021-2026)
Figure 68. Egypt Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Ophthalmic Phacoemulsification Surgery System Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Ophthalmic Phacoemulsification Surgery System in 2026
Figure 74. Manufacturing Process Analysis of Ophthalmic Phacoemulsification Surgery System
Figure 75. Industry Chain Structure of Ophthalmic Phacoemulsification Surgery System
Figure 76. Channels of Distribution
Figure 77. Global Ophthalmic Phacoemulsification Surgery System Sales Market Forecast by Region (2027-2032)
Figure 78. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Ophthalmic Phacoemulsification Surgery System Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Ophthalmic Phacoemulsification Surgery System Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Ophthalmic Phacoemulsification Surgery System Revenue Market Share Forecast by Application (2027-2032)
